C T Hu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C T Hu

Showing results (31-40 of 49) with videos related to

Pageof 5

Sort By:

IEEE Transactions on Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|April 25, 2000

A novel speech controller for radio amateurs with a vision impairmentC L Lin, B R Bai, L C Du, et al.

Oncotarget|May 17, 2014

Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancersChong-kui Sun, Fan Zhang, Tao Xiang, et al.

American Journal of Cancer Research|April 12, 2022

FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cellsYoung Min Chung, Wen Bin Tsai, Pragya P Khan, et al.

The Journal of Biological Chemistry|November 8, 2001

Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinaseGuisheng Zhou, Kathie A Mihindukulasuriya, Rebecca A MacCorkle-Chosnek, et al.

Plos One|July 14, 2010

Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse modelWen-Bin Tsai, Young Min Chung, Yiyu Zou, et al.

Journal for Immunotherapy of Cancer|December 10, 2021

Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3Young Min Chung, Pragya P Khan, Hong Wang, et al.

Journal of the American Society of Nephrology : JASN|November 4, 2006

Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney diseaseMitsuo Kato, Hang Yuan, Zhong-Gao Xu, et al.

Breast Cancer Research : BCR|March 4, 2008

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesisYiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, et al.

Nature Communications|August 16, 2012

FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damageYoung Min Chung, See-Hyoung Park, Wen-Bin Tsai, et al.

The Journal of Pathology|January 15, 2023

SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinomaYi-Mei Lee, Yu-Hsin Chen, Da-Liang Ou, et al.

Pageof 5

Search research articles

Showing results (31-40 of 49) with videos related to

Sort By:

Pageof 5

IEEE Transactions on Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|April 25, 2000

A novel speech controller for radio amateurs with a vision impairmentC L Lin, B R Bai, L C Du, et al.

Oncotarget|May 17, 2014

Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancersChong-kui Sun, Fan Zhang, Tao Xiang, et al.

American Journal of Cancer Research|April 12, 2022

FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cellsYoung Min Chung, Wen Bin Tsai, Pragya P Khan, et al.

The Journal of Biological Chemistry|November 8, 2001

Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinaseGuisheng Zhou, Kathie A Mihindukulasuriya, Rebecca A MacCorkle-Chosnek, et al.

Plos One|July 14, 2010

Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse modelWen-Bin Tsai, Young Min Chung, Yiyu Zou, et al.

Journal for Immunotherapy of Cancer|December 10, 2021

Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3Young Min Chung, Pragya P Khan, Hong Wang, et al.

Journal of the American Society of Nephrology : JASN|November 4, 2006

Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney diseaseMitsuo Kato, Hang Yuan, Zhong-Gao Xu, et al.

Breast Cancer Research : BCR|March 4, 2008

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesisYiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, et al.

Nature Communications|August 16, 2012

FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damageYoung Min Chung, See-Hyoung Park, Wen-Bin Tsai, et al.

The Journal of Pathology|January 15, 2023

SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinomaYi-Mei Lee, Yu-Hsin Chen, Da-Liang Ou, et al.

Pageof 5